Skip to content

Dose-response relationship of tegileridine in inhibiting propofol-induced responses to laryngeal mask airway insertion: A sequential trial

Dose-response relationship of tegileridine in inhibiting propofol-induced responses to laryngeal mask airway insertion: A sequential trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122713
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:According to the modified Dixon sequential method, the dose of tegileridine for laryngeal mask airway insertion during propofol induction was determined. The first patient received

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. Age 18-65 years old; 3. Body mass index 18-30 kg/m^2; 4. Male and female patients requiring propofol-induced endotracheal intubation for general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Refuse to participate in this study; 2. Unable to cooperate or communicate in Chinese; 3. Participate in other clinical studies; 4. Currently taking any painkillers; 5. Abuse of opioid drugs; 6. Suffering from diseases such as heart, brain, liver, and kidney disorders; 7. for laryngeal mask insertion due to full stomach, facial deformity, or difficulty in opening the mouth; 8. Hypertension, tachycardia, etc., with unstable hemodynamics.

Design outcomes

Primary

MeasureTime frame
Laryngeal mask airway insertion response score;

Secondary

MeasureTime frame
The highest values of MAP and HR and the lowest values of SPO2 were observed during the induction period after tegiladine injection;The incidence of hypertension, hypotension, bradycardia, tachycardia, and hypoxemia (SpO? < 90%) during the induction period after tegileridine injection.;The use of ephedrine and atropine during the induction period.;The requirement for additional propofol during the induction period.;The Ramsay Sedation Score of patients at 3 minutes after tegileridine injection.;Number of laryngeal mask airway insertion attempts;Conversion to general anesthesia with endotracheal intubation;Incidence of pain during propofol injection;Incidence of propofol injection pain;BIS latency, defined as the time interval from patient awakening to the decrease of BIS to 60 after tegileridine injection.;Incidence of adverse reactions (including coughing during induction, muscle rigidity, muscle tremors, limb movement, hiccups, allergic reactions, dizziness, etc.).;Patient baseline characteristics;

Countries

China

Contacts

Public ContactZhang Jingyu

Lanzhou University Second Hospital

zjy_83817@163.com+86 138 9339 5974

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026